MYLEEN LEONCAVALLO
co-founder & chief scientific officer
Myleen Leoncavallo is an accomplished scientific executive with a stellar career in rare diseases in the pharmaceutical industry spanning over 26 years. Her extensive expertise lies in leading regulatory affairs, drug development, and drug registration with global regulatory agencies such as the FDA and the EMA. In short, she gets the much needed rare disease medications approved worldwide. She is passionate about exploring natural health alternatives and sharing this with others.
experience
In her career, Myleen has held several leadership positions, such as a Senior VP and Head of Regulatory, where she played a pivotal role leading and contributing to the successful development and approval of 9 pharmaceutical products, earning her recognition in the top 5-10% of industry professionals. Myleen's areas of specialization span a wide range of medical disciplines, including Metabolism and Endocrinology, Gastroenterology, Neurology, Dermatology, and Cardiovascular. With graduate degrees in Regulatory Science and Pharmaceutical Chemistry from the University of Southern California in Los Angeles and an undergraduate degree in Biochemistry & Cell Biology from the University of California in San Diego, Myleen possesses a deep understanding of the scientific rigor, regulatory landscape, and compliance requirements that governs the pharmaceutical industry. Her comprehensive knowledge in these fields has allowed her to make impactful contributions to the advancement of drug therapies and the improvement of patient outcomes.
Although Myleen has dedicated her efforts in the development and approvals of pharmaceuticals, she is also driven by her passion for exploring natural health alternatives and their efficacy in improving overall well-being. She brings her strategic insights, scientific acumen, and extensive experience in the pharmaceutical industry and applies it to our organization by selecting some of the best equipment and therapies that offer the highest effectiveness for relaxation and stress management at a reasonable cost. Her expertise ensures that our offerings align with the highest standards of quality, safety, and efficacy, providing the masses with an affordable luxury that promotes wellness and tranquility.
Myleen's exceptional scientific background, extensive regulatory knowledge, and commitment to natural health alternatives make her an invaluable asset to our organization. Her strategic guidance and contributions are instrumental in our mission to deliver effective and accessible relaxation solutions to a wide audience.